Zobrazeno 1 - 10
of 317
pro vyhledávání: '"Stéphane, Auvin"'
Autor:
Nazanin Azarinejad Mohammadi, Philip Kiær Ahring, Vivian Wan Yu Liao, Han Chow Chua, Sebastián Ortiz de la Rosa, Katrine Marie Johannesen, Yael Michaeli-Yossef, Aline Vincent-Devulder, Catherine Meridda, Ange-Line Bruel, Alessandra Rossi, Chirag Patel, Joerg Klepper, Paolo Bonanni, Sara Minghetti, Marina Trivisano, Nicola Specchio, David Amor, Stéphane Auvin, Sarah Baer, Pierre Meyer, Mathieu Milh, Vincenzo Salpietro, Reza Maroofian, Johannes R. Lemke, Sarah Weckhuysen, Palle Christophersen, Guido Rubboli, Mary Chebib, Anders A. Jensen, Nathan L. Absalom, Rikke Steensbjerre Møller
Publikováno v:
EBioMedicine, Vol 106, Iss , Pp 105236- (2024)
Summary: Background: Variants in GABRB2, encoding the β2 subunit of the γ-aminobutyric acid type A (GABAA) receptor, can result in a diverse range of conditions, ranging from febrile seizures to severe developmental and epileptic encephalopathies.
Externí odkaz:
https://doaj.org/article/1f75a6fe61cf4a01b76139af961cda76
Autor:
Sylvain Rheims, Vania Herbillon, Ségolène Gaillard, Catherine Mercier, Nathalie Villeuve, Frédéric Villéga, Claude Cances, Pierre Castelnau, Silvia Napuri, Anne de Saint‐Martin, Stéphane Auvin, Sylvie Nguyen The Tich, Patrick Berquin, Julitta deBellecize, Mathieu Milh, Pascal Roy, Alexis Arzimanoglou, Jacques Bodennec, Laurent Bezin, Behrouz Kassai, the investigators of the AGPI study group
Publikováno v:
Epilepsia Open, Vol 9, Iss 2, Pp 582-591 (2024)
Abstract Background Attention‐deficit hyperactivity disorder (ADHD) is a frequent comorbidity in children with epilepsy, which management mostly relies on the usual treatments of ADHD, especially methylphenidate. Supplementation with polyunsaturate
Externí odkaz:
https://doaj.org/article/03fdfbd8a42046a6802ce5d305b1cc28
Autor:
Stéphane Auvin
Publikováno v:
Epilepsy & Behavior Reports, Vol 26, Iss , Pp 100660- (2024)
A case study of a child with childhood absence epilepsy and hyperactivity introduces the discussion around the psychiatric diagnosis, differential considerations, and pharmacologic treatment options for ADHD/hyperactivity in children with epilepsy. M
Externí odkaz:
https://doaj.org/article/7e406c53176243cdad9d95e3f9f895e6
Autor:
Denis Pouchain, Stéphane Auvin, Helen Shaw, Nathalie Texier, Pierre Fayoux, Mickael Dinomais, Nick Probert, Frédéric Villain
Publikováno v:
BMJ Paediatrics Open, Vol 7, Iss 1 (2023)
Introduction Severe sialorrhoea is a common, distressing problem in children/adolescents with neurodisabilities, which has adverse health and social consequences. The SALIVA trial is designed to evaluate the efficacy and safety of a paediatric-specif
Externí odkaz:
https://doaj.org/article/8eecbd584ddb484bb882f8f454a786c2
Autor:
Jo Sourbron, Stéphane Auvin, Alexis Arzimanoglou, J. Helen Cross, Hans Hartmann, Ronit Pressler, Kate Riney, Kenji Sugai, Jo M. Wilmshurst, Elissa Yozawitz, Lieven Lagae
Publikováno v:
Epilepsia Open, Vol 8, Iss 1, Pp 77-89 (2023)
Abstract Objective Antiseizure medications (ASMs) remain the mainstay of epilepsy treatment. These ASMs have mainly been tested in trials in adults with epilepsy, which subsequently led to market authorization (MA). For treatment of – especially yo
Externí odkaz:
https://doaj.org/article/d7e8ed31b1b44f2d8effbe4dcf7b5c7a
Autor:
Soline Roy, Stéphane Auvin
L'épilepsie est une maladie fréquente qui touche 1% de la population et suscite encore beaucoup de croyances populaires. Il s'agit en fait d'un groupe de maladies différentes, et on devrait plutôt parler'des'épilepsies. Elles débutent le plus s
Autor:
Walid Khrouf, Dario Saracino, Benoit Rucheton, Marion Houot, Fabienne Clot, Daisy Rinaldi, Joana Vitor, Marie Huynh, Evelyne Heng, Dimitri Schlemmer, Florence Pasquier, Vincent Deramecourt, Sophie Auriacombe, Carole Azuar, Richard Levy, Stéphanie Bombois, Claire Boutoleau-Brétonnière, Jérémie Pariente, Mira Didic, David Wallon, Frédérique Fluchère, Stéphane Auvin, Imen Ben Younes, Yann Nadjar, Alexis Brice, Bruno Dubois, Dominique Bonnefont-Rousselot, Isabelle Le Ber, Foudil Lamari
Publikováno v:
Neurobiology of Disease, Vol 181, Iss , Pp 106108- (2023)
GRN mutations are among the main genetic causes of frontotemporal dementia (FTD). Considering the progranulin involvement in lysosomal homeostasis, we aimed to evaluate if plasma lysosphingolipids (lysoSPL) are increased in GRN mutation carriers, and
Externí odkaz:
https://doaj.org/article/74d41b87d2e9459a8fa3e729c04253b6
Autor:
Claudio Liguori, Estevo Santamarina, Adam Strzelczyk, Juan Jesús Rodríguez-Uranga, Rohit Shankar, Xiana Rodríguez-Osorio, Stéphane Auvin, Paolo Bonanni, Eugen Trinka, Rob McMurray, Ricardo Sáinz-Fuertes, Vicente Villanueva
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
IntroductionThe PERMIT study is the largest pooled analysis of perampanel (PER) clinical practice data conducted to date.MethodsThis post-hoc analysis of PERMIT investigated the effectiveness, safety and tolerability of PER when used as early add-on
Externí odkaz:
https://doaj.org/article/1d156cae057a4f7181f5a1605d5679ea
Autor:
Elena Cardenal‐Muñoz, Stéphane Auvin, Vicente Villanueva, J. Helen Cross, Sameer M. Zuberi, Lieven Lagae, José Ángel Aibar
Publikováno v:
Epilepsia Open, Vol 7, Iss 1, Pp 11-26 (2022)
Abstract Dravet syndrome (DS) is a severe, rare, and complex developmental and epileptic encephalopathy affecting 1 in 16 000 live births and characterized by a drug‐resistant epilepsy, cognitive, psychomotor, and language impairment, and behaviora
Externí odkaz:
https://doaj.org/article/6f738f3396a94d8e9441daf564c14571
Autor:
Sandrine Passemard, Albert Faye, Caroline Dubertret, Hugo Peyre, Camille Vorms, Victor Boimare, Stéphane Auvin, Martin Flamant, Philippe Ruszniewski, Jean-Damien Ricard
Publikováno v:
BMC Medical Education, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Many initiatives have emerged worldwide to handle the surge of hospitalizations during the SARS-CoV-2 pandemic. In France, the University of Paris North called on its medical students, whose status makes them integral members of t
Externí odkaz:
https://doaj.org/article/99939e225f244f5a80ecba18882a14e5